• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗志贺毒素的治疗性抗体:趋势与展望。

Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.

机构信息

Laboratório de Bacteriologia, Instituto Butantan, São Paulo, Brazil.

Laboratorio de Fisiopatogenia, Instituto de Fisiología y Biofísica Bernardo Houssay (IFIBIO Houssay-CONICET), Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

出版信息

Front Cell Infect Microbiol. 2022 Feb 10;12:825856. doi: 10.3389/fcimb.2022.825856. eCollection 2022.

DOI:10.3389/fcimb.2022.825856
PMID:35223548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8866733/
Abstract

Shiga toxins (Stx) are AB-type toxins, composed of five B subunits which bind to Gb host cell receptors and an active A subunit, whose action on the ribosome leads to protein synthesis suppression. The two Stx types (Stx1 and Stx2) and their subtypes can be produced by Shiga toxin-producing strains and some spp. These bacteria colonize the colon and induce diarrhea that may progress to hemorrhagic colitis and in the most severe cases, to hemolytic uremic syndrome, which could lead to death. Since the use of antibiotics in these infections is a topic of great controversy, the treatment remains supportive and there are no specific therapies to ameliorate the course. Therefore, there is an open window for Stx neutralization employing antibodies, which are versatile molecules. Indeed, polyclonal, monoclonal, and recombinant antibodies have been raised and tested and assays, showing differences in their neutralizing ability against deleterious effects of Stx. These molecules are in different phases of development for which we decide to present herein an updated report of these antibody molecules, their source, advantages, and disadvantages of the promising ones, as well as the challenges faced until reaching their applicability.

摘要

志贺毒素(Stx)是一种 AB 型毒素,由五个 B 亚基组成,这些 B 亚基与 Gb 宿主细胞受体结合,而活性 A 亚基在核糖体上起作用,导致蛋白质合成抑制。两种志贺毒素类型(Stx1 和 Stx2)及其亚型可由产志贺毒素菌株和一些 spp 产生。这些细菌定植于结肠并诱导腹泻,腹泻可能进展为出血性结肠炎,在最严重的情况下,进展为溶血性尿毒综合征,可能导致死亡。由于在这些感染中使用抗生素是一个极具争议的话题,因此治疗仍然是支持性的,没有专门的疗法可以改善病程。因此,使用抗体中和 Stx 有一个开放的窗口,抗体是多功能分子。事实上,已经制备和测试了多克隆、单克隆和重组抗体,以及 测定,显示它们对 Stx 有害影响的中和能力存在差异。这些分子处于不同的开发阶段,我们决定在此介绍这些抗体分子的最新报告,包括它们的来源、优势和劣势,以及在达到适用性之前面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/341ac2ff6839/fcimb-12-825856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/9c684c4d48fc/fcimb-12-825856-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/1e842d8743b6/fcimb-12-825856-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/341ac2ff6839/fcimb-12-825856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/9c684c4d48fc/fcimb-12-825856-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/1e842d8743b6/fcimb-12-825856-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee2/8866733/341ac2ff6839/fcimb-12-825856-g003.jpg

相似文献

1
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.抗志贺毒素的治疗性抗体:趋势与展望。
Front Cell Infect Microbiol. 2022 Feb 10;12:825856. doi: 10.3389/fcimb.2022.825856. eCollection 2022.
2
A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.一种基于单个 VHH 的毒素中和剂和一种效应抗体可保护小鼠免受志贺毒素 1 和 2 的攻击。
Infect Immun. 2013 Dec;81(12):4592-603. doi: 10.1128/IAI.01033-13. Epub 2013 Sep 30.
3
The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.志贺毒素2的A1亚基对核糖体的亲和力和催化活性高于志贺毒素1的A1亚基。
Infect Immun. 2015 Oct 19;84(1):149-61. doi: 10.1128/IAI.00994-15. Print 2016 Jan.
4
AB5 Preassembly Is Not Required for Shiga Toxin Activity.志贺毒素活性不需要AB5预组装。
J Bacteriol. 2016 May 13;198(11):1621-1630. doi: 10.1128/JB.00918-15. Print 2016 Jun 1.
5
Characterization of rabbit polyclonal sera against recombinant Shiga toxin and its subunits for detection of Stx-producing E. coli.用于检测产志贺毒素大肠杆菌的抗重组志贺毒素及其亚基兔多克隆血清的特性分析
Iran J Allergy Asthma Immunol. 2011 Mar;10(1):41-6.
6
Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.通过用志贺毒素B亚基经皮免疫来预防产志贺毒素大肠杆菌感染
Clin Vaccine Immunol. 2008 Feb;15(2):359-66. doi: 10.1128/CVI.00399-07. Epub 2007 Nov 14.
7
Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.能够识别并在体外中和产志贺毒素大肠杆菌的Stx2毒素的重组抗体片段的开发与特性分析
PLoS One. 2015 Mar 19;10(3):e0120481. doi: 10.1371/journal.pone.0120481. eCollection 2015.
8
A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.一种多聚-N-乙酰葡萄糖胺-志贺毒素广谱缀合物疫苗,用于产志贺毒素大肠杆菌。
mBio. 2014 Mar 25;5(2):e00974-14. doi: 10.1128/mBio.00974-14.
9
Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing .产志贺毒素大肠埃希菌的近期治疗应用及感染策略
Front Cell Infect Microbiol. 2021 Jun 29;11:614963. doi: 10.3389/fcimb.2021.614963. eCollection 2021.
10
Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies.夹心酶联免疫吸附试验用鸡卵黄免疫球蛋白 Y 抗体检测产志贺毒素大肠杆菌。
Front Cell Infect Microbiol. 2012 Jun 18;2:84. doi: 10.3389/fcimb.2012.00084. eCollection 2012.

引用本文的文献

1
In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Based on the 2011 German O104:H4 Outbreak Strain Using Reverse Vaccinology and an Immunoinformatic Approach.基于2011年德国O104:H4疫情菌株,采用反向疫苗学和免疫信息学方法对肠道致病菌多表位疫苗进行计算机辅助设计。
Diseases. 2025 Aug 13;13(8):259. doi: 10.3390/diseases13080259.
2
Shiga Toxins Produced by Enterohaemorrhagic Induce Inflammation in Toxin-Sensitive Cells through the p38 MAPK/MK2/Tristetraprolin Signaling Pathway.肠出血性大肠杆菌产生的志贺毒素通过p38丝裂原活化蛋白激酶/丝裂原活化蛋白激酶2/锌指蛋白信号通路在毒素敏感细胞中诱导炎症。
J Microbiol Biotechnol. 2024 Dec 28;34(12):2439-2449. doi: 10.4014/jmb.2410.10016. Epub 2024 Nov 22.
3

本文引用的文献

1
The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.FabF8:Stx2 重组单克隆抗体在体外中和志贺毒素 2 型的有害作用。
Toxins (Basel). 2021 Nov 22;13(11):825. doi: 10.3390/toxins13110825.
2
Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina.阿根廷溶血性尿毒症综合征产志贺毒素大肠杆菌的流行病学及特征分析
Cureus. 2021 Aug 16;13(8):e17213. doi: 10.7759/cureus.17213. eCollection 2021 Aug.
3
Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing .
Isolation and Characterization of Novel O157:H7 Phage SPEC13 as a Therapeutic Agent for Infections In Vitro and In Vivo.
新型O157:H7噬菌体SPEC13的分离与鉴定及其作为体外和体内感染治疗剂的研究
Biomedicines. 2024 Sep 6;12(9):2036. doi: 10.3390/biomedicines12092036.
4
Mechanisms of antibody-dependent enhancement of infectious disease.抗体依赖性传染病增强机制。
Nat Rev Immunol. 2025 Jan;25(1):6-21. doi: 10.1038/s41577-024-01067-9. Epub 2024 Aug 9.
5
What is the role of microbial biotechnology and genetic engineering in medicine?微生物生物技术和遗传工程在医学中的作用是什么?
Microbiologyopen. 2024 Apr;13(2):e1406. doi: 10.1002/mbo3.1406.
6
Production of egg yolk antibody (IgY) against a chimeric protein containing IpaD, StxB, and TolC antigens from Shigella: An investigation of its prophylactic effects against Shiga toxin (Stx) and and .抗包含志贺氏菌IpaD、StxB和TolC抗原的嵌合蛋白的蛋黄抗体(IgY)的制备:对其抗志贺毒素(Stx)预防作用的研究 以及 。 (注:原文结尾处不完整,翻译时尽量忠实原文表述)
Heliyon. 2024 Feb 16;10(4):e26361. doi: 10.1016/j.heliyon.2024.e26361. eCollection 2024 Feb 29.
7
Characterization of the novel temperate Escherichia coli phage phiStx2k.新型温和性大肠杆菌噬菌体phiStx2k的特性分析
Arch Virol. 2023 Dec 11;169(1):5. doi: 10.1007/s00705-023-05941-0.
8
A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy.一种新型的具有低免疫原性和高效力的志贺毒素 2a 中和抗体治疗药物。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0059823. doi: 10.1128/aac.00598-23. Epub 2023 Dec 4.
9
Enzymatic Cleavage of Stx2a in the Gut and Identification of Pancreatic Elastase and Trypsin as Possible Main Cleavers.肠道中Stx2a的酶促切割以及胰腺弹性蛋白酶和胰蛋白酶作为可能主要切割酶的鉴定。
Microorganisms. 2023 Oct 4;11(10):2487. doi: 10.3390/microorganisms11102487.
10
Diagnosis and Treatment for Shiga Toxin-Producing Associated Hemolytic Uremic Syndrome.产志贺样毒素大肠埃希菌相关性溶血尿毒综合征的诊断与治疗。
Toxins (Basel). 2022 Dec 23;15(1):10. doi: 10.3390/toxins15010010.
产志贺毒素大肠埃希菌的近期治疗应用及感染策略
Front Cell Infect Microbiol. 2021 Jun 29;11:614963. doi: 10.3389/fcimb.2021.614963. eCollection 2021.
4
Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.巴氏杀菌和喷雾干燥工艺后,高免抗 Stx2 牛初乳对肠出血性大肠杆菌 O157:H7 致病性的保护能力的保持。
J Dairy Sci. 2021 May;104(5):5229-5238. doi: 10.3168/jds.2020-19709. Epub 2021 Mar 6.
5
Antibodies to watch in 2021.2021 年值得关注的抗体药物
MAbs. 2021 Jan-Dec;13(1):1860476. doi: 10.1080/19420862.2020.1860476.
6
Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.严重的小儿肠出血性大肠杆菌相关溶血尿毒症综合征(STEC-HUS)患者在早期即有多器官受累。
Pediatr Nephrol. 2021 Jun;36(6):1499-1509. doi: 10.1007/s00467-020-04829-4. Epub 2020 Nov 17.
7
An Overview of the Elusive Passenger in the Gastrointestinal Tract of Cattle: The Shiga Toxin Producing .牛胃肠道中难以捉摸的过客概述:产志贺毒素的……
Microorganisms. 2020 Jun 10;8(6):877. doi: 10.3390/microorganisms8060877.
8
Treatment Strategies for Infections With Shiga Toxin-Producing .产志贺毒素大肠埃希氏菌感染的治疗策略。
Front Cell Infect Microbiol. 2020 May 6;10:169. doi: 10.3389/fcimb.2020.00169. eCollection 2020.
9
Production of egg yolk antibody (IgY) against shiga-like toxin (stx) and evaluation of its prophylaxis potency in mice.生产针对志贺样毒素 (stx) 的蛋黄抗体 (IgY) 及其在小鼠中的预防效果评价。
Microb Pathog. 2020 Aug;145:104199. doi: 10.1016/j.micpath.2020.104199. Epub 2020 Apr 19.
10
Verotoxin Receptor-Based Pathology and Therapies.基于维罗毒素受体的病理学与治疗方法
Front Cell Infect Microbiol. 2020 Mar 31;10:123. doi: 10.3389/fcimb.2020.00123. eCollection 2020.